Az ENDORSE-2-HUNGARIA. vizsgálat eredményei: Az akut kórházi betegek vénásthromboembolia- kockázatának és -profilaxisának ismételt hazai felmérése

Translated title of the contribution: Results of ENDORSE-2-HUNGARIA study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting

Hajna Losonczy, Attila Tar, Dénes László, Kardos Mária, Gurzó Mihály, Klucsik Zsolt, Ledniczki István, Al Absi Seif, Kecskés Gábor, Wrana Gyozo, Kovács József, Szemerédi László, Mayer Klára, Jójárt István, Pusztai Dezso, Szalisznyó Ilona, Szabó Ibolya, Ruzsa Csaba, Bernáth Béla, M. ZeherG. Kerekes

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study in 2006, was a multinational cross-sectional survey designed to assess the prevalence of venous thromboembolism (VTE) risk in the acute hospital care setting, and to determine the proportion of at-risk patients who receive appropriate prophylaxis. From the 358 randomly selected hospitals across 32 countries in the global registry, 9 Hungarian centers were included. According to the Hungarian results, the use of appropriate prophylaxis was more common in surgical patients but much less common in medical patients comparing to the worldwide average. ENDORSE 2-HUNGARY was a local survey to compare the prophylactic habits after two years and two months time period. In both surveys, the 2004 American College of Chest Physicians (ACCP) evidence-based consensus guidelines were used to assess venous thromboembolism risk and to determine whether patients were receiving recommended prophylaxis. The one day survey ENDORSE 2-HUNGARY was repeated beside seven already audited hospitals, and in two newly recruited hospitals. A total of 886 patients were assessed for thrombosis risk on the basis of hospital chart review. Of these patients 59.0% (N=523) were judged at risk for VTE, including 100% (N=327) surgical and 35.1% (N=196) medical patients. 67.9% (N=355) of the total at-risk patients received ACCP-recommended VTE prophylaxis. Among surgical patients, 84.4% (N=276) received recommended prophylaxis compared with 40.3% (N=79) of medical patients. Results of the ENDORSE in 2006 and 2009 were compared, as well. The rate of appropriate prophylaxis use in at-risk patients did not changed significantly in surgical patients, however, a significant, 43.9% increase was found in medical patients (p=0.002), that proves the success of lectures presenting the facts and focusing to increase medical prophylaxis during the time period between the two studies. 59.7% of at-risk medical patients and 15.6% of surgical patients were unprotected against thrombosis in 2009. We should further increase the rate of at-risk patients receiving appropriate prophylaxis. We should reinforce the rationale for the increase of awareness of VTE risk in hospitalized medical patients, and to enhance the prophylaxis practice among healthcare professionals.

Original languageHungarian
Pages (from-to)843-852
Number of pages10
JournalOrvosi Hetilap
Volume151
Issue number21
DOIs
Publication statusPublished - May 1 2010

Fingerprint

Venous Thromboembolism
Thrombosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az ENDORSE-2-HUNGARIA. vizsgálat eredményei : Az akut kórházi betegek vénásthromboembolia- kockázatának és -profilaxisának ismételt hazai felmérése. / Losonczy, Hajna; Tar, Attila; László, Dénes; Mária, Kardos; Mihály, Gurzó; Zsolt, Klucsik; István, Ledniczki; Seif, Al Absi; Gábor, Kecskés; Gyozo, Wrana; József, Kovács; László, Szemerédi; Klára, Mayer; István, Jójárt; Dezso, Pusztai; Ilona, Szalisznyó; Ibolya, Szabó; Csaba, Ruzsa; Béla, Bernáth; Zeher, M.; Kerekes, G.

In: Orvosi Hetilap, Vol. 151, No. 21, 01.05.2010, p. 843-852.

Research output: Contribution to journalArticle

Losonczy, H, Tar, A, László, D, Mária, K, Mihály, G, Zsolt, K, István, L, Seif, AA, Gábor, K, Gyozo, W, József, K, László, S, Klára, M, István, J, Dezso, P, Ilona, S, Ibolya, S, Csaba, R, Béla, B, Zeher, M & Kerekes, G 2010, 'Az ENDORSE-2-HUNGARIA. vizsgálat eredményei: Az akut kórházi betegek vénásthromboembolia- kockázatának és -profilaxisának ismételt hazai felmérése', Orvosi Hetilap, vol. 151, no. 21, pp. 843-852. https://doi.org/10.1556/OH.2010.28895
Losonczy, Hajna ; Tar, Attila ; László, Dénes ; Mária, Kardos ; Mihály, Gurzó ; Zsolt, Klucsik ; István, Ledniczki ; Seif, Al Absi ; Gábor, Kecskés ; Gyozo, Wrana ; József, Kovács ; László, Szemerédi ; Klára, Mayer ; István, Jójárt ; Dezso, Pusztai ; Ilona, Szalisznyó ; Ibolya, Szabó ; Csaba, Ruzsa ; Béla, Bernáth ; Zeher, M. ; Kerekes, G. / Az ENDORSE-2-HUNGARIA. vizsgálat eredményei : Az akut kórházi betegek vénásthromboembolia- kockázatának és -profilaxisának ismételt hazai felmérése. In: Orvosi Hetilap. 2010 ; Vol. 151, No. 21. pp. 843-852.
@article{946482b0c2a943bb9c3c966847c38198,
title = "Az ENDORSE-2-HUNGARIA. vizsg{\'a}lat eredm{\'e}nyei: Az akut k{\'o}rh{\'a}zi betegek v{\'e}n{\'a}sthromboembolia- kock{\'a}zat{\'a}nak {\'e}s -profilaxis{\'a}nak ism{\'e}telt hazai felm{\'e}r{\'e}se",
abstract = "ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study in 2006, was a multinational cross-sectional survey designed to assess the prevalence of venous thromboembolism (VTE) risk in the acute hospital care setting, and to determine the proportion of at-risk patients who receive appropriate prophylaxis. From the 358 randomly selected hospitals across 32 countries in the global registry, 9 Hungarian centers were included. According to the Hungarian results, the use of appropriate prophylaxis was more common in surgical patients but much less common in medical patients comparing to the worldwide average. ENDORSE 2-HUNGARY was a local survey to compare the prophylactic habits after two years and two months time period. In both surveys, the 2004 American College of Chest Physicians (ACCP) evidence-based consensus guidelines were used to assess venous thromboembolism risk and to determine whether patients were receiving recommended prophylaxis. The one day survey ENDORSE 2-HUNGARY was repeated beside seven already audited hospitals, and in two newly recruited hospitals. A total of 886 patients were assessed for thrombosis risk on the basis of hospital chart review. Of these patients 59.0{\%} (N=523) were judged at risk for VTE, including 100{\%} (N=327) surgical and 35.1{\%} (N=196) medical patients. 67.9{\%} (N=355) of the total at-risk patients received ACCP-recommended VTE prophylaxis. Among surgical patients, 84.4{\%} (N=276) received recommended prophylaxis compared with 40.3{\%} (N=79) of medical patients. Results of the ENDORSE in 2006 and 2009 were compared, as well. The rate of appropriate prophylaxis use in at-risk patients did not changed significantly in surgical patients, however, a significant, 43.9{\%} increase was found in medical patients (p=0.002), that proves the success of lectures presenting the facts and focusing to increase medical prophylaxis during the time period between the two studies. 59.7{\%} of at-risk medical patients and 15.6{\%} of surgical patients were unprotected against thrombosis in 2009. We should further increase the rate of at-risk patients receiving appropriate prophylaxis. We should reinforce the rationale for the increase of awareness of VTE risk in hospitalized medical patients, and to enhance the prophylaxis practice among healthcare professionals.",
keywords = "K{\'o}rh{\'a}zi belgy{\'o}gy{\'a}szati {\'e}s seb{\'e}szeti betegek, Nemzetk{\"o}zi keresztmetszeti vizsg{\'a}lat, Prevalence, Profilaxis, Rizik{\'o}faktor, V{\'e}n{\'a}s thromboembolia, Venous tromboembolism",
author = "Hajna Losonczy and Attila Tar and D{\'e}nes L{\'a}szl{\'o} and Kardos M{\'a}ria and Gurz{\'o} Mih{\'a}ly and Klucsik Zsolt and Ledniczki Istv{\'a}n and Seif, {Al Absi} and Kecsk{\'e}s G{\'a}bor and Wrana Gyozo and Kov{\'a}cs J{\'o}zsef and Szemer{\'e}di L{\'a}szl{\'o} and Mayer Kl{\'a}ra and J{\'o}j{\'a}rt Istv{\'a}n and Pusztai Dezso and Szaliszny{\'o} Ilona and Szab{\'o} Ibolya and Ruzsa Csaba and Bern{\'a}th B{\'e}la and M. Zeher and G. Kerekes",
year = "2010",
month = "5",
day = "1",
doi = "10.1556/OH.2010.28895",
language = "Hungarian",
volume = "151",
pages = "843--852",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "21",

}

TY - JOUR

T1 - Az ENDORSE-2-HUNGARIA. vizsgálat eredményei

T2 - Az akut kórházi betegek vénásthromboembolia- kockázatának és -profilaxisának ismételt hazai felmérése

AU - Losonczy, Hajna

AU - Tar, Attila

AU - László, Dénes

AU - Mária, Kardos

AU - Mihály, Gurzó

AU - Zsolt, Klucsik

AU - István, Ledniczki

AU - Seif, Al Absi

AU - Gábor, Kecskés

AU - Gyozo, Wrana

AU - József, Kovács

AU - László, Szemerédi

AU - Klára, Mayer

AU - István, Jójárt

AU - Dezso, Pusztai

AU - Ilona, Szalisznyó

AU - Ibolya, Szabó

AU - Csaba, Ruzsa

AU - Béla, Bernáth

AU - Zeher, M.

AU - Kerekes, G.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study in 2006, was a multinational cross-sectional survey designed to assess the prevalence of venous thromboembolism (VTE) risk in the acute hospital care setting, and to determine the proportion of at-risk patients who receive appropriate prophylaxis. From the 358 randomly selected hospitals across 32 countries in the global registry, 9 Hungarian centers were included. According to the Hungarian results, the use of appropriate prophylaxis was more common in surgical patients but much less common in medical patients comparing to the worldwide average. ENDORSE 2-HUNGARY was a local survey to compare the prophylactic habits after two years and two months time period. In both surveys, the 2004 American College of Chest Physicians (ACCP) evidence-based consensus guidelines were used to assess venous thromboembolism risk and to determine whether patients were receiving recommended prophylaxis. The one day survey ENDORSE 2-HUNGARY was repeated beside seven already audited hospitals, and in two newly recruited hospitals. A total of 886 patients were assessed for thrombosis risk on the basis of hospital chart review. Of these patients 59.0% (N=523) were judged at risk for VTE, including 100% (N=327) surgical and 35.1% (N=196) medical patients. 67.9% (N=355) of the total at-risk patients received ACCP-recommended VTE prophylaxis. Among surgical patients, 84.4% (N=276) received recommended prophylaxis compared with 40.3% (N=79) of medical patients. Results of the ENDORSE in 2006 and 2009 were compared, as well. The rate of appropriate prophylaxis use in at-risk patients did not changed significantly in surgical patients, however, a significant, 43.9% increase was found in medical patients (p=0.002), that proves the success of lectures presenting the facts and focusing to increase medical prophylaxis during the time period between the two studies. 59.7% of at-risk medical patients and 15.6% of surgical patients were unprotected against thrombosis in 2009. We should further increase the rate of at-risk patients receiving appropriate prophylaxis. We should reinforce the rationale for the increase of awareness of VTE risk in hospitalized medical patients, and to enhance the prophylaxis practice among healthcare professionals.

AB - ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study in 2006, was a multinational cross-sectional survey designed to assess the prevalence of venous thromboembolism (VTE) risk in the acute hospital care setting, and to determine the proportion of at-risk patients who receive appropriate prophylaxis. From the 358 randomly selected hospitals across 32 countries in the global registry, 9 Hungarian centers were included. According to the Hungarian results, the use of appropriate prophylaxis was more common in surgical patients but much less common in medical patients comparing to the worldwide average. ENDORSE 2-HUNGARY was a local survey to compare the prophylactic habits after two years and two months time period. In both surveys, the 2004 American College of Chest Physicians (ACCP) evidence-based consensus guidelines were used to assess venous thromboembolism risk and to determine whether patients were receiving recommended prophylaxis. The one day survey ENDORSE 2-HUNGARY was repeated beside seven already audited hospitals, and in two newly recruited hospitals. A total of 886 patients were assessed for thrombosis risk on the basis of hospital chart review. Of these patients 59.0% (N=523) were judged at risk for VTE, including 100% (N=327) surgical and 35.1% (N=196) medical patients. 67.9% (N=355) of the total at-risk patients received ACCP-recommended VTE prophylaxis. Among surgical patients, 84.4% (N=276) received recommended prophylaxis compared with 40.3% (N=79) of medical patients. Results of the ENDORSE in 2006 and 2009 were compared, as well. The rate of appropriate prophylaxis use in at-risk patients did not changed significantly in surgical patients, however, a significant, 43.9% increase was found in medical patients (p=0.002), that proves the success of lectures presenting the facts and focusing to increase medical prophylaxis during the time period between the two studies. 59.7% of at-risk medical patients and 15.6% of surgical patients were unprotected against thrombosis in 2009. We should further increase the rate of at-risk patients receiving appropriate prophylaxis. We should reinforce the rationale for the increase of awareness of VTE risk in hospitalized medical patients, and to enhance the prophylaxis practice among healthcare professionals.

KW - Kórházi belgyógyászati és sebészeti betegek

KW - Nemzetközi keresztmetszeti vizsgálat

KW - Prevalence

KW - Profilaxis

KW - Rizikófaktor

KW - Vénás thromboembolia

KW - Venous tromboembolism

UR - http://www.scopus.com/inward/record.url?scp=77952635008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952635008&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28895

DO - 10.1556/OH.2010.28895

M3 - Article

C2 - 20462844

AN - SCOPUS:77952635008

VL - 151

SP - 843

EP - 852

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 21

ER -